148 related articles for article (PubMed ID: 12767359)
21. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
22. The use of complementary and alternative medicine among Chinese women with breast cancer.
Chen Z; Gu K; Zheng Y; Zheng W; Lu W; Shu XO
J Altern Complement Med; 2008 Oct; 14(8):1049-55. PubMed ID: 18928393
[TBL] [Abstract][Full Text] [Related]
23. Complementary and Alternative Medicine Use and Symptom Burden in Women Undergoing Chemotherapy for Breast Cancer in Malaysia.
Chui PL; Abdullah KL; Wong LP; Taib NA
Cancer Nurs; 2018; 41(3):189-199. PubMed ID: 28723722
[TBL] [Abstract][Full Text] [Related]
24. Complementary and alternative medicine among Singapore cancer patients.
Chow WH; Chang P; Lee SC; Wong A; Shen HM; Verkooijen HM
Ann Acad Med Singap; 2010 Feb; 39(2):129-35. PubMed ID: 20237735
[TBL] [Abstract][Full Text] [Related]
25. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract][Full Text] [Related]
26. Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 patient populations.
Helpman L; Ferguson SE; Mackean M; Rana A; Le L; Atkinson MA; Rogerson A; Mackay H
Int J Gynecol Cancer; 2011 Apr; 21(3):587-93. PubMed ID: 21436708
[TBL] [Abstract][Full Text] [Related]
27. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
[TBL] [Abstract][Full Text] [Related]
28. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?
Keyser D; Kupelian PA; Zippe CD; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):723-9. PubMed ID: 9240638
[TBL] [Abstract][Full Text] [Related]
29. Complementary and alternative medicine use by osteoporosis clinic patients.
Chong CA; Diaz-Granados N; Hawker GA; Jamal S; Josse RG; Cheung AM
Osteoporos Int; 2007 Nov; 18(11):1547-56. PubMed ID: 17603742
[TBL] [Abstract][Full Text] [Related]
30. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation.
Porter M; Kolva E; Ahl R; Diefenbach MA
Complement Ther Med; 2008 Dec; 16(6):318-24. PubMed ID: 19028331
[TBL] [Abstract][Full Text] [Related]
31. Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey.
Irmak Z; Tanrıverdi Ö; Ödemiş H; Uysal DD
Complement Ther Med; 2019 Jun; 44():143-150. PubMed ID: 31126547
[TBL] [Abstract][Full Text] [Related]
32. Complementary and alternative medicine use in radiotherapy: what are patients using?
Gillett J; Ientile C; Hiscock J; Plank A; Martin JM
J Altern Complement Med; 2012 Nov; 18(11):1014-20. PubMed ID: 22906192
[TBL] [Abstract][Full Text] [Related]
33. Attitudes about the use of complementary and alternative medicine in cancer treatment.
Schernhammer ES; Haidinger G; Waldhör T; Vutuc C
J Altern Complement Med; 2009 Oct; 15(10):1115-20. PubMed ID: 19848548
[TBL] [Abstract][Full Text] [Related]
34. Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution.
Yoshimura K; Ueda N; Ichioka K; Matsui Y; Terai A; Arai Y
Support Care Cancer; 2005 Sep; 13(9):685-90. PubMed ID: 15947954
[TBL] [Abstract][Full Text] [Related]
35. Information needs and usage of complementary and alternative medicine in members of a German self-help group for gastrointestinal stroma tumours, sarcoma, and renal cancer.
Bauer F; Schmidt T; Eisfeld H; Dubois C; Kastrati K; Hochhaus A; Huebner J
Complement Ther Med; 2018 Dec; 41():105-110. PubMed ID: 30477825
[TBL] [Abstract][Full Text] [Related]
36. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.
Zuniga KB; Zhao S; Kenfield SA; Cedars B; Cowan JE; Van Blarigan EL; Broering JM; Carroll PR; Chan JM
J Urol; 2019 Oct; 202(4):689-695. PubMed ID: 31091175
[TBL] [Abstract][Full Text] [Related]
37. A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.
Lee WR; Hall MC; McQuellon RP; Case LD; McCullough DL
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):614-23. PubMed ID: 11597800
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features.
Saini A; Berruti A; Capogna S; Negro M; Sguazzotti E; Picci RL; Campagna S; Dongiovanni V; Dogliotti L; Furlan PM; Ostacoli L
Qual Life Res; 2011 Jun; 20(5):683-90. PubMed ID: 21080084
[TBL] [Abstract][Full Text] [Related]
39. Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.
Kang E; Yang EJ; Kim SM; Chung IY; Han SA; Ku DH; Nam SJ; Yang JH; Kim SW
Support Care Cancer; 2012 Mar; 20(3):461-73. PubMed ID: 21274576
[TBL] [Abstract][Full Text] [Related]
40. Correlation of [11C]choline PET-CT with time to treatment and disease-specific survival in men with recurrent prostate cancer after radical prostatectomy.
Breeuwsma AJ; Rybalov M; Leliveld AM; Pruim J; de Jong IJ
Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):440-6. PubMed ID: 23069923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
